References
- Tallman M. S., Hakiminan D., Variakojis D., Koslow D., Sisney G. A., Rakemaker A. W., Rose E., Kaul K. A single cycle of 2-chlorodoxyadenosine results in complete remission in the majority of patients with hairy cell leukaemia. Blood 1992; 80(9)2203–2209
- Julliusson G., Lenkeil R., Lillimark J. Flow cytometry of blood and bone marrow cells from patients with hairy cell leukaemia: Phenotype with hairy cells and lymphocyte subsets after treatment with 2-chlorodoxyadenosine. Blood 1994; 83(12)3672–-3681
- Van Den Nest E., Delannoy A, Vandercam B., Bosly A., Ferrant A., Mineur P., Montfort L., Martiat P., Straetmans N., Filleul B., Michaux J. L. Infectious complications after 2-chlorodeoxyadenosine therapy. European Journal of Haematology 1996; 56(4)235–-40
- Betticher D.C., Fey M. F., von Rohr A., Tobler A., Jenzer H., Gratwohl A., Lohri A., Pugin P., Pagani O., Zulian G., Cerny T. High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias. Annals of Oncology 1994; 5: 57–64
- Benson C. A., Ellner J. J. Mycobacterium avium complex infection and AIDS: Advances in theory and practice. Clinical Infectious Diseases 1993; 17: 7–20